Product Description
Beijing Hope Pharmaceutical Co., Ltd. is a high-tech pharmaceutical company based in China and facing the world. The main business is R&D, production and sales of APIs and APIs, import and export trade, R&D of new pharmaceutical preparations and new drug registration. We have an R&D center in Beijing, a pharmaceutical intermediate production base in Hebei and Zhejiang, and a GMP-certified API production base in Shandong.
AI Product Description
*The following content is generated by AI and is for reference only.
(+)-Dehydroisoandrosterone, often referred to as (+)-DHEA or specifically the dextrorotatory isomer of dehydroepiandrosterone, is a significant endogenous steroid hormone naturally produced by the adrenal glands. With the Chemical Abstracts Service (CAS) registry number 531-69-5, this compound possesses the molecular formula C₁₉H₂₈O₂ and a precise molecular weight of approximately 288.42 g/mol. Structurally, it features a characteristic steroid backbone with a ketone group at the C3 position and a double bond between carbons 4 and 5, distinguishing it from its saturated counterpart, dihydrotestosterone. The "(+)" designation indicates its specific optical activity, reflecting the spatial arrangement of atoms that defines its unique interaction with biological receptors compared to other stereoisomers.
In terms of application, (+)-DHEA serves primarily as a crucial precursor in the biosynthesis of potent sex hormones, including testosterone and estradiol. Consequently, it plays an indispensable role in regulating various physiological processes such as immune function, bone density maintenance, and lipid metabolism. In the pharmaceutical and nutraceutical industries, this molecule is extensively researched for its potential anti-aging properties and its ability to support cognitive health and mood regulation, particularly in aging populations where endogenous production declines significantly. While standard DHEA supplements often contain racemic mixtures, the isolated (+)-isomer offers a targeted approach for specific therapeutic interventions where stereochemical purity is critical for efficacy and safety.
Furthermore, research suggests that (+)-DHEA may exhibit distinct metabolic pathways compared to its (-)-counterpart, influencing how it modulates estrogenic and androgenic activities within different tissues. This specificity makes it valuable in specialized medical studies exploring hormonal imbalances, adrenal insufficiency, and certain autoimmune conditions. However, due to its potent hormonal nature, its use is strictly regulated in many jurisdictions, requiring careful dosage management under professional supervision to avoid adverse effects like virilization or hormonal disruption. As a fundamental building block in steroid biochemistry, understanding the unique profile of (+)-Dehydroisoandrosterone remains essential for advancing endocrinology and developing next-generation hormonal therapies.